King Gen PCL (BKK:KGEN)

Checkpoint Therapeutics Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,337	2,311	1,151	2,271	1,237	675
Market Cap Growth	2.54%	100.84%	-49.34%	83.64%	83.33%	162.50%
Enterprise Value	2,416	3,253	1,113	1,942	1,303	718
Last Close Price	0.67	1.40	0.92	1.72	0.94	0.51
PE Ratio	-	-	-	-	-	15.66
Forward PE	-	25.57	25.57	25.57	25.57	25.57
PS Ratio	1.68	3.11	2.36	3557.66	7.10	1.13
PB Ratio	1.53	2.78	1.48	3.64	2.01	0.94
P/TBV Ratio	1.72	3.20	1.82	3.76	12.98	1.69
P/FCF Ratio	-	69.70	-	13.75	-	19.10
P/OCF Ratio	-	46.68	-	13.40	-	5.18
EV/Sales Ratio	3.04	4.38	2.28	3042.55	7.48	1.21
EV/EBITDA Ratio	-	-	54.70	-	45.37	5.35
EV/EBIT Ratio	-	-	-	-	-	11.78
EV/FCF Ratio	39.83	98.12	-	11.76	-	20.33
Debt / Equity Ratio	1.27	1.33	0.33	0.30	0.32	0.11
Debt / EBITDA Ratio	147.98	21.50	6.80	-	6.85	0.53
Debt / FCF Ratio	18.26	33.23	-	1.14	-	2.26
Asset Turnover	0.41	0.45	0.44	0.00	0.17	0.69
Inventory Turnover	347.23	208.71	51.52	-	13.46	37.75
Quick Ratio	0.69	0.73	1.68	1.58	1.23	1.17
Current Ratio	0.75	0.76	1.74	2.40	1.33	1.32
Return on Equity (ROE)	-30.70%	-27.16%	-2.54%	-12.21%	-4.46%	9.16%
Return on Assets (ROA)	-6.30%	-6.64%	-5.53%	-4.84%	-1.85%	4.38%
Return on Capital (ROIC)	-6.94%	-7.47%	-6.61%	-5.81%	-2.29%	5.98%
Return on Capital Employed (ROCE)	-	-	-	-	-	7.50%
Earnings Yield	-15.11%	-7.97%	-1.66%	-2.56%	-8.39%	6.39%
FCF Yield	4.54%	1.44%	-5.96%	7.27%	-4.88%	5.24%
Buyback Yield / Dilution	-22.84%	-17.11%	-6.19%	-	-47.16%	-42.70%
Total Shareholder Return	-	-17.11%	-6.19%	-	-47.16%	-42.70%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.